M14-675
ClinicalTrials.gov NCT03653026
Research payments
$6,599,461
Through program year 2020, $6,599,461 in research payments was reported against M14-675, across 851 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03653026
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $3,589,392 | 513 |
| 2019 | Research | $3,010,068 | 338 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Henry Levine Orlando, FL Named on 51 payments
- Harry Ojeas Houston, TX Named on 38 payments
- Joe Pouzar Houston, TX Named on 37 payments
- Michael Bennett San Diego, CA Named on 24 payments
- Paul Hellstern Crystal River, FL Named on 23 payments
- Gorman Reynolds Cincinnati, OH Named on 22 payments
- Charles Johnson Mobile, AL Named on 20 payments
- Esther Torres San Juan, PR Named on 19 payments
- Mark Fleisher Jacksonville, FL Named on 18 payments
- George Duvall Vero Beach, FL Named on 16 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.